Pfizer
Louise Proud has extensive experience in environmental, health, and safety (EHS) roles, currently serving as Vice President of Global Environment, Health & Safety at Pfizer since October 1998. Previous positions at Pfizer include Senior Director roles overseeing EHS in various sectors, including R&D and commercial operations. Prior to joining Pfizer, Louise Proud worked as an Occupational Hygienist at the Institute of Occupational Medicine from March 1995 to September 1998 and as a Safety Engineer at NEC Semiconductors. Louise Proud holds a Master of Science in Occupational Hygiene from the University of Aberdeen and a Bachelor of Science in Chemistry from The University of Edinburgh.
This person is not in any offices
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.